It helps regenerate fibroblasts (the workhorse cells of tissue repair) and promotes new blood vessel and nerve growthboth essential for proper recovery
Type 2 Diabetes: In the Lancet Phase 2 trial, retatrutide reduced HbA1c by up to 2.16 percentage points at the highest doses, accompanied by a robust weight reduction (~17% at 36 weeks)
Factors like energy density, viscosity, and moisture content significantly influence gastric emptying, which in turn affects digestion, satiety, and the severity of GI symptoms [60]
A decrease of plasma acid phosphatase and serum alkaline phosphatase occurred by the 10th week in patients with stage C disease presenting with prostatism, showing a major clinical improvement
Gastrointestinal side effects such as diarrhoea are most common during the dose-escalation phase of retatrutide treatment and often improve or resolve once a stable maintenance dose is reached